197 related articles for article (PubMed ID: 30418556)
1. Regional Body Fat Changes and Metabolic Complications in Children With Dunnigan Lipodystrophy-Causing LMNA Variants.
Patni N; Li X; Adams-Huet B; Vasandani C; Gomez-Diaz RA; Garg A
J Clin Endocrinol Metab; 2019 Apr; 104(4):1099-1108. PubMed ID: 30418556
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of Anthropometric Measurements for Familial Partial Lipodystrophy, Dunnigan Variety.
Vasandani C; Li X; Sekizkardes H; Adams-Huet B; Brown RJ; Garg A
J Clin Endocrinol Metab; 2020 Jul; 105(7):2132-41. PubMed ID: 32193531
[TBL] [Abstract][Full Text] [Related]
3. Describing the natural history of clinical, biochemical and radiological outcomes of children with familial partial lipodystrophy type 2 (FPLD2) from the United Kingdom: A retrospective case series.
Zhong ZX; Harris J; Wilber E; Gorman S; Savage DB; O'Rahilly S; Stears A; Williams RM
Clin Endocrinol (Oxf); 2022 Dec; 97(6):755-762. PubMed ID: 35920656
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Dietary Intake, Leisure-Time Physical Activity, and Metabolic Profile in Women with Mutation in the LMNA Gene.
Monteiro L; Foss-Freitas MC; Navarro A; Pereira F; Coeli F; Carneseca E; Júnior RM; Foss M
J Am Coll Nutr; 2017; 36(4):248-252. PubMed ID: 28443701
[TBL] [Abstract][Full Text] [Related]
5. Irisin levels in LMNA-associated partial lipodystrophies.
Bensmaïne F; Benomar K; Espiard S; Vahe C; Le Mapihan K; Lion G; Lemdani M; Chazard E; Ernst O; Vigouroux C; Pigny P; Vantyghem MC
Diabetes Metab; 2019 Jan; 45(1):67-75. PubMed ID: 30165155
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic diversity and glucocorticoid sensitivity in patients with familial partial lipodystrophy type 2.
Resende ATP; Martins CS; Bueno AC; Moreira AC; Foss-Freitas MC; de Castro M
Clin Endocrinol (Oxf); 2019 Jul; 91(1):94-103. PubMed ID: 30954027
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic Differences Among Familial Partial Lipodystrophy Due to
Vasandani C; Li X; Sekizkardes H; Brown RJ; Garg A
J Endocr Soc; 2022 Oct; 6(12):bvac155. PubMed ID: 36397776
[TBL] [Abstract][Full Text] [Related]
8. FPLD2 LMNA mutation R482W dysregulates iPSC-derived adipocyte function and lipid metabolism.
Friesen M; Cowan CA
Biochem Biophys Res Commun; 2018 Jan; 495(1):254-260. PubMed ID: 29108996
[TBL] [Abstract][Full Text] [Related]
9. [Familial partial lipodystrophy (Dunnigan syndrome) due to LMNA gene mutation: The first description of its clinical case in Russia].
Sorkina EL; Kalashnikova MF; Melnichenko GA; Tyulpakov AN
Ter Arkh; 2015; 87(3):83-87. PubMed ID: 26027246
[TBL] [Abstract][Full Text] [Related]
10. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.
Bidault G; Garcia M; Vantyghem MC; Ducluzeau PH; Morichon R; Thiyagarajah K; Moritz S; Capeau J; Vigouroux C; Béréziat V
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2162-71. PubMed ID: 23846499
[TBL] [Abstract][Full Text] [Related]
11. High-throughput Second-generation Sequencing Technology Assisted Diagnosis of Familial Partial Lipodystrophy (Type 2 Kobberling-Dunnigan Syndrome): A Case Report.
Deng M; Chen W; Qi Y
Comb Chem High Throughput Screen; 2024; 27(2):346-351. PubMed ID: 37231758
[TBL] [Abstract][Full Text] [Related]
12. A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies.
Treiber G; Flaus Furmaniuk A; Guilleux A; Medjane S; Bonfanti O; Schneebeli S; Bernard C; Le-Moullec N; Bakiri F; Pholsena M; Rollot O; Vatier C; Jarlet E; Jéru I; Lascols O; Darcel F; Domun B; Venault A; Venault S; Jacquemont ML; Doray B; Maiza JC; Cogne M; Vigouroux C; Nobécourt E
Eur J Endocrinol; 2021 Aug; 185(4):453-462. PubMed ID: 34292171
[TBL] [Abstract][Full Text] [Related]
13. The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation.
Wojtanik KM; Edgemon K; Viswanadha S; Lindsey B; Haluzik M; Chen W; Poy G; Reitman M; Londos C
J Lipid Res; 2009 Jun; 50(6):1068-79. PubMed ID: 19201734
[TBL] [Abstract][Full Text] [Related]
14. Familial partial lipodystrophy presenting as metabolic syndrome.
Chan D; McIntyre AD; Hegele RA; Don-Wauchope AC
J Clin Lipidol; 2016; 10(6):1488-1491. PubMed ID: 27919367
[TBL] [Abstract][Full Text] [Related]
15. Clinical Spectrum of
Fernandez-Pombo A; Diaz-Lopez EJ; Castro AI; Sanchez-Iglesias S; Cobelo-Gomez S; Prado-Moraña T; Araujo-Vilar D
Cells; 2023 Feb; 12(5):. PubMed ID: 36899861
[TBL] [Abstract][Full Text] [Related]
16. Generation of an integration-free induced pluripotent stem cell line (PUMCHi001-A) from a patient with familial partial lipodystrophy type 2 (FPLD2) carrying a heterozygous p.R349W (c.1045C > T) mutation in the LMNA gene.
Xiao C; Yu M; Liu J; Wu H; Deng M; Zhang Q; Xiao X
Stem Cell Res; 2020 Jan; 42():101651. PubMed ID: 31794942
[TBL] [Abstract][Full Text] [Related]
17. Severe loss of adipose tissue in a Vietnamese lipodystrophy patient caused by
Vu NP; Tran HT; Vu NB; Ma TTH; Nguyen TD; Nong HV; Nguyen HH
J Pediatr Endocrinol Metab; 2022 Sep; 35(9):1206-1210. PubMed ID: 35822709
[TBL] [Abstract][Full Text] [Related]
18. Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy.
Araújo-Vilar D; Lattanzi G; González-Méndez B; Costa-Freitas AT; Prieto D; Columbaro M; Mattioli E; Victoria B; Martínez-Sánchez N; Ramazanova A; Fraga M; Beiras A; Forteza J; Domínguez-Gerpe L; Calvo C; Lado-Abeal J
J Med Genet; 2009 Jan; 46(1):40-8. PubMed ID: 18805829
[TBL] [Abstract][Full Text] [Related]
19. Thiazolidinedione response in familial lipodystrophy patients with LMNA mutations: a case series.
Luedtke A; Boschmann M; Colpe C; Engeli S; Adams F; Birkenfeld AL; Haufe S; Rahn G; Luft FC; Schmidt HH; Jordan J
Horm Metab Res; 2012 Apr; 44(4):306-11. PubMed ID: 22274718
[TBL] [Abstract][Full Text] [Related]
20. Generation of an isogenic gene-corrected iPSC line (PUMCHi001-A-1) from a familial partial lipodystrophy type 2 (FPLD2) patient with a heterozygous R349W mutation in the LMNA gene.
Xiao C; Yu M; Liu J; Wu H; Deng M; Zhang Q; Xiao X
Stem Cell Res; 2020 Apr; 44():101753. PubMed ID: 32213461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]